Tag Archives: FDA

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease, while the CMS continues to restrict its use

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities to consolidate and strengthen and expand their pharmacy reach and drug contracts

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Eisai Selects Soleo Health as Sole Specialty Pharmacy Provider for Leqembi

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, was selected by Eisai as the sole specialty pharmacy distribution partner for Leqembi

Onco360 Selected as Pharmacy Partner for Tibsovo and ORGOVYX®

Onco360, the nation’s largest independent Oncology Pharmacy and clinical support services company, was recently selected to be the pharmacy partner for Tibsovo and ORGOVYX®

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults